All Known In Vivo Functions of the Oct-2 Transcription Factor Require the C-Terminal Protein Domain

Journal of Immunology

Volumn 172, Issue 5, 2004, Pages 2962-2969

  Corcoran, Lynn M ^a   Koentgen, Frank ^b   Dietrich, Wendy ^a   Veale, Margaret ^a   Humbert, Patrick O ^c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Ozgene   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; OCTAMER TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CARBOXY TERMINAL SEQUENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 1342324683     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.5.2962     Document Type: Article

References (58)

1. Staudt, L. M., R. G. Clerc, H. Singh, J. H. LeBowitz, P. A. Sharp, and D. Baltimore. 1988. Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science 241:577.
2. Clerc, R. G., L. M. Corcoran, J. H. LeBowitz, D. Baltimore, and P. A. Sharp. 1988. The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. Genes Dev. 2:1570.
3. Kang, S. M., W. Tsang, S. Doll, P. Scherle, H. S. Ko, A. C. Tran, M. J. Lenardo, and L. M. Staudt. 1992. Induction of the POU domain transcription factor Oct-2 during T-cell activation by cognate antigen. Mol. Cell. Biol. 12:3149.
4. Cockerill, P. N., and S. P. Klinken. 1990. Octamer-binding proteins in diverse hemopoietic cells. Mol. Cell. Biol. 10:1293.
5. Humbert, P. O., and L. M. Corcoran. 1997, Oct-2 gene disruption eliminates the peritoneal B-1 lymphocyte lineage and attenuates B-2 cell maturation and function. J. Immunol. 159:5273.
6. Corcoran, L. M., and M. Karvelas. 1994. Oct-2 is required early in T cell-independent B cell activation for G1 progression and for proliferation. Immunity 1:635.
7. Corcoran, L. M., M. Karvelas, G. J. Nossal, Z. S. Ye, T. Jacks, and D. Baltimore. 1993. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7:570.
8. Feldhaus, A. L., C. A. Klug, K. L. Arvin, and H. Singh. 1993. Targeted disruption of the Oct-2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element-mediated gene activation. EMBO J. 12:2763.
9. Pfisterer, P., J. Hess, and T. Wirth. 1997. Identification of target genes of the lymphoid-specific transcription factor Oct2. Immunobiology 198:217.
10. Konig, H., P. Pfisterer, L. M. Corcoran, and T. Wirth, 1995. Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev. 9:1598.
11. Shore, P., W. Dietrich, and L. M. Corcoran. 2002. Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1. Nucleic Acids Res. 30:1767.
12. Corcoran, L. M., D. Vremec, M. Febbraio, T. Baldwin, and E. Handman. 2002. Differential regulation of CD36 expression in antigen-presenting cells: Oct-2 dependence in B lymphocytes but not dendritic cells or macrophages. Int. Immunol. 14:1099.
13. Herr, W., R. A. Sturm, R. G. Clerc, L. M. Corcoran, D. Baltimore, P. A. Sharp, H. A. Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkun, et al. 1988. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 2:1513.
14. Strubin, M., J. W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific co-activator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80:497.
15. Luo, Y., and R. G. Roeder. 1995. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional co-activator OCA-B. Mol. Cell. Biol. 15:4115.
16. Muller-Immergluck, M. M., W. Schaffner, and P. Matthias. 1990. Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells. EMBO J. 9:1625.
17. Tanaka, M., and W. Herr. 1990. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60:375.
18. Sivaraja, M., M. C. Botfield, M. Mueller, A. Jancso, and M. A. Weiss. 1994. Solution structure of a POU-specific homeodomain: 3D-NMR studies of human B-cell transcription factor Oct-2. Biochemistry 33:9845.
19. Klemm, J. D., M. A. Rould, R. Aurora, W. Herr, and C. O. Pabo. 1994. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77:21.
20. Inamoto, S., N. Segil, Z. Q. Pan, M. Kimura, and R. G. Roeder, 1997. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors. J. Biol. Chem. 272:29852.
21. Arnosti, D. N., A. Merino, D. Reinberg, and W. Schaffner. 1993. Oct-2 facilitates functional preinitiation complex assembly and is continuously required at the promoter for multiple rounds of transcription. EMBO J. 12:157.
22. Bertolino, E., and H. Singh. 2002. POU/TBP cooperativity: a mechanism for enhancer action from a distance. Mol Cell 10:397.
23. Friedl, E. M., and P. Matthias. 1995. Transcriptional activation and repression, two properties of the lymphoid-specific transcription factor Oct-2a. Eur. J. Biochem. 234:308.
24. Annweiler, A., S. Zwilling, and T. Wirth. 1994. Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms. Nucleic Acids Res. 22:4250.
25. Sharif, M. N., H. S. Radomska, D. M. Miller, and L. A. Eckhardt. 2001. Unique function for carboxyl-terminal domain of Oct-2 in Ig-secreting cells. J. Immunol. 167:4421.
26. Wirth, T., A. Priess, A. Annweiler, S. Zwilling, and B. Oeler. 1991. Multiple Oct2 isoforms are generated by alternative splicing. Nucleic Acids Res. 19:43.
27. Wu, H., X. Liu, and R. Jaenisch. 1994. Double replacement: strategy for efficient introduction of subtle mutations into the murine Colla-I gene by homologous recombination in embryonic stem cells. Proc. Natl. Acad. Sci. USA 91:2819.
28. Köntgen, F., and C. L. Stewart. 1993. Simple screening procedure to detect gene targeting events in embryonic stem cells. Methods Enzymol. 225:878.
29. Gu, H., Y. R. Zou, and K. Rajewsky. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through CreloxP-mediated gene targeting. Cell 73:1155.
30. Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
31. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
32. Hatzopoulos, A. K., A. S. Stoykova, J. R. Erselius, M. Goulding, T. Neuman, and P. Gruss. 1990. Structure and expression of the mouse Oct2a and Oct2b, two differentially spliced products of the same gene. Development 109:349.
33. Stoykova, A. S., S. Sterrer, J. R. Erselius, A. K. Hatzopoulos, and P. Gruss. 1992. Mini-Oct and Oct-2c: two novel, functionally diverse murine Oct-2 gene products are differentially expressed in the CNS. Neuron 8:541.
34. Lakso, M., J. G. Pichel, J. R. Gorman, B. Sauer, Y. Okamoto, E. Lee, F. W. Alt, and H. Westphal. 1996. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93:5860.
35. Corcoran, L. M., and D. Metcalf. 1999. IL-5 and Rp105 signaling defects in B cells from commonly used 129 mouse substrains. J. Immunol. 163:5836.
36. Hardy, R. R., Y. S. Li, D. Allman, M. Asano, M. Gui, and K. Hayakawa. 2000. B-cell commitment, development and selection. Immunol. Rev. 175:23.
37. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15.
38. Allman, D. M., S. E. Ferguson, and M. P. Cancro. 1992. Peripheral B cell maturation. I. Immature peripheral B cells in adults are heat-stable antigen(hi) and exhibit unique signaling characteristics. J. Immunol. 149:2533.
39. Allman, D. M., S. E. Ferguson, V. M. Lentz, and M. P. Cancro. 1993. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 151:4431.
40. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75.
41. Carsetti, R., G. Kohler, and M. C. Lamers. 1995. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 181:2129.
42. Norvell, A., L. Mandik, and J. G. Monroe. 1995. Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J. Immunol. 154:4404.
43. Bendall, H. H., D. C. Scherer, C. R. Edson, D. W. Ballard, and E. M. Oltz. 1997. Transcription factor NF-κB regulates inducible Oct-2 gene expression in precursor B lymphocytes. J. Biol. Chem. 272:28826.
44. Pfisterer, P., H. Konig, J. Hess, G. Lipowsky, B. Haendler, W. D. Schleuning, and T. Wirth. 1996. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol. Cell. Biol. 16:6160.
45. Kristie, T. M., and P. A. Sharp. 1990. Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV α-trans-activator protein. Genes Dev. 4:2383.
46. Stem, S., and W. Herr. 1991. The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. Genes Dev. 5:2555.
47. Abdulkadir, S. A., V. Casolaro, A. K. Tai, D. Thanos, and S. J. Ono. 1998. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains. J. Leukocyte Biol. 64:681.
48. Tang, H., and P. A. Sharp. 1999. Transcriptional regulation of the murine 3′ IgH enhancer by OCT-2. Immunity 11:517.
49. Grenfell, S. J., D. S. Latchman, and N. S. Thomas. 1996. Oct-1 [corrected] and Oct-2 DNA-binding site specificity is regulated in vitro by different kinases. Biochem. J. 315(Pt. 3):889.
50. Pevzner, V., R. Kraft, S. Kostka, and M. Lipp. 2000. Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability. Biochem. J. 347(Pt. 1):29.
51. Kennelly, P. J., and E. G. Krebs. 1991. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266:15555.
52. Pinna, L. A., and M. Ruzzene. 1996. How do protein kinases recognize their substrates? Biochim. Biophys. Acta 1314:191.
53. Mead, J., K. Elliston, D. F. Mark, and S. W. Ludmerer. 1994. The C-terminus of the B cell activator Oct-2 functions as an activation domain in yeast. Biochem. Biophys. Res. Commun. 205:1998.
54. Seipel, K., O. Georgiev, and W. Schaffner. 1992. Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J. 11:4961.
55. Zwilling, S., A. Annweiler, and T. Wirth. 1994. The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. Nucleic Acids Res. 22:1655.
56. Dent, C. L., K. A. Lillycrop, J. K. Estridge, N. S. Thomas, and D. S. Latchman. 1991. The B-cell and neuronal forms of the octamer-binding protein Oct-2 differ in DNA-binding specificity and functional activity. Mol. Cell. Biol. 11:3925.
57. Grignani, F., T. Kinsella, A. Mencarelli, M. Valtieri, D. Riganelli, F. Grignani, L. Lanfrancone, C. Peschle, G. P. Nolan, and P. G. Pelicci. 1998. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58:14.
58. Krebs, D. L., Y. Yang, M. Dang, J. Haussmann, and M. R. Gold. 1999. Rapid and efficient retrovirus-mediated gene transfer into B cell lines. Methods Cell Sci. 21:57.